Intraocular hemorrhage developing during interferon therapy

Internal Medicine

Volumn 35, Issue 1, 1996, Pages 15-18

  Kuga, Kazuhito ^a   Hasumura, Satoshi ^a   Nagamori, Seishi ^a   Toda, Gotaro ^a   Kitahara, Kenji ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

chronic active hepatitis C; interferon; ocular hemorrhage

Indexed keywords

BETA INTERFERON; INTERFERON;

ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; HEPATITIS C; HUMAN; HYPEREMIA; INTRAOCULAR HEMORRHAGE; INTRAOCULAR PRESSURE ABNORMALITY; MALE; VISUAL IMPAIRMENT;

EID: 0030012297     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.15     Document Type: Article

References (13)

1. Suzuki S, Takeuchi T, Ito E, et al. Clinical results of treatment with natural human interferon-β (MR-21) in patients with chronic hepatitis B. J of Clinical Therapeutics & Medicine 5: 2087, 1989.
2. Koga M, Yano U. Interferon therapy for chronic non-A, non-B hepatitis. J of Clinical and Experimental Medicine 151: 871, 1989.
3. Furue H. Dosage, administration and side effects of interferon: Based on its in vivo kinetics. Japanese J of Cancer and Chemotherapy 11: 186. 1984.
4. Ikebe T, Nakatsuka K, Goto M, Sakai Y. A case of retinopathy induced by intravenous administration of Interferon. Folia Ophthalmol Jpn 41: 2291, 1990.
5. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 111: 350, 1993.
6. Miyamoto K, Suda T, Motokura M, et al. Retinopathy in Interferon-α treatment. Journal of the Eye 10: 497, 1993.
7. Scott GM, Secher DS, Flowers D, et al. Toxicity of interferon. Br Med J 282: 1345, 1981
8. Retsas S, Priestrnan TJ, Newton KA, et al. Evaluation of human lymphoblastoid interferon in advanced malignant melanoma. Cancer 51: 273, 1983.
9. Sherwin SA, Knost JA, Abrams PG, et al. A multiple-dose phase I trial of recombinant leukocyte α-interferon in cancer patients. J Am Med Assoc 248: 2461, 1982.
10. Averbuch SD, Austin III HA, Sherwin SA, et al. Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte α-interferon therapy for mycosis fungoides. N Engl J Med 32: 310, 1984.
11. Yano U, Fujiyama S, Sada M, et al. Clinical assessment of interferon-β (MR-21) therapy in patients with chronic non-A, non-B hepatitis. The J of Medicine and Pharmaceutical Science 27: 1022, 1992.
12. Kado M, Yoshida T, Sakagami K. A patient who experienced panophthalmitis during interferon therapy. Jpn J Clin Ophthalmol 48: 692, 1994.
13. Seki K, Ito Y, Nishi Y, Inosaka Y. Interferon therapy and bleeding of the ocular fundus in chronic active hepatitis C. Acta Hepatologica Japonica 34: 385, 1993.